Catalyst Wire Dossier Catalyst Wire Dossier

Immunoradiotherapy combinations

· Genmab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunoradiotherapy combinations, covering 2026-07-02 to 2026-07-02. Get the full timeline:

Most recent: Clinical Trial Results: A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors [Phase 1, Phase 2]

See pricing